# Assessing the Clinical Effectiveness of Serum Biomarkers in the Diagnosis of Metastatic Uveal Melanoma

> **NCT01438658** · — · RECRUITING · sponsor: **Hadassah Medical Organization** · enrollment: 250 (estimated)

## Conditions studied

- Uveal Melanoma

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01438658
- **Lead sponsor:** Hadassah Medical Organization
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2011-09
- **Primary completion:** 2040-12
- **Final completion:** 2040-12
- **Target enrollment:** 250 (ESTIMATED)
- **Last updated:** 2011-09-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01438658

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01438658, "Assessing the Clinical Effectiveness of Serum Biomarkers in the Diagnosis of Metastatic Uveal Melanoma". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01438658. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*